Lyra

Govee Launches Two Stylish New Floor Lamps To Enhance Spaces

Retrieved on: 
Monday, April 15, 2024
Rotation, Lyra, Nature, Pro, Love, Dance, Floor, Life, Yoga, Bluetooth, Lighting, Torchère, Temperature, Sleep, Meditation

HONG KONG, April 15, 2024 /PRNewswire/ -- Govee announces the launch of its latest offerings in the smart interior lighting, the Floor Lamp 2 and Floor Lamp Pro. Building on the brand's commitment to "Make Life Smarter," these state-of-the-art lamps are designed to elevate contemporary living spaces with versatile light solutions. From soft, ambient mood lighting to clear, focused brightness, these lamps blend functionality and style to enhance the modern home experience.

Key Points: 
  • Building on the brand's commitment to "Make Life Smarter," these state-of-the-art lamps are designed to elevate contemporary living spaces with versatile light solutions.
  • From soft, ambient mood lighting to clear, focused brightness, these lamps blend functionality and style to enhance the modern home experience.
  • As Govee continues to innovate and expand its product line, the Floor Lamp Series evolves with the goal of transforming spaces to enhance lifestyles.
  • The Govee Floor Lamp Pro will become available on both sites for $219.99 on April 22, 2024.

Lyra Health Study Finds COVID-19 Delayed Trauma Response Taking a Growing Toll on Workers’ Mental Health Worldwide

Retrieved on: 
Tuesday, March 12, 2024
Technology, Professional Services, Health, Mental Health, Health Technology, Apps, Applications, Software, Artificial Intelligence, Human Resources, Telemedicine, Virtual Medicine, COVID-19, Depression, HR, Organization, Burnout, Lyra, Risk, Mental, Mental health, Trauma, Child, Anxiety, Workforce, Suicidal ideation, AT&T, Suicide, Substance use disorder, Workplace, Dysthymia, Nursing

Lyra Health , the leading provider of innovative Workforce Mental Health solutions for employers, today announced the findings of its 2024 State of Workforce Mental Health report .

Key Points: 
  • Lyra Health , the leading provider of innovative Workforce Mental Health solutions for employers, today announced the findings of its 2024 State of Workforce Mental Health report .
  • While organizations have made progress in promoting and supporting mental health care for mild and moderate issues such as stress and anxiety, the study also points to a rise in complex mental health conditions since 2021.
  • One of the drivers of these increases is the delayed trauma response to the COVID-19 pandemic.
  • Lyra's 2024 State of Workforce Mental Health report also revealed the second most significant factor negatively impacting U.S. workers' mental health is work-related stress and burnout.

Novel research leverages AI to identify dogs at higher risk for cancer

Retrieved on: 
Tuesday, March 26, 2024
B-cell lymphoma, Intelligence, Partnership, Risk, Research, DNA, Golden, Cancer, University, Mammal, Morris Animal Foundation, Veterinarian, Human, Dog, Lymphoma, Comparative medicine, Lyra, Cat, Blood, Animal, DLBCL, Ageing

Findings may help identify dogs at higher risk for DLBCL.

Key Points: 
  • Findings may help identify dogs at higher risk for DLBCL.
  • The team plans to provide pet owners and veterinarians with intervention strategies to help lower the risk in identified dogs.
  • Beyond its direct impact on dogs, this research effort could influence numerous research avenues in other mammals, including cats, endangered species and even humans, Modiano added.
  • The approach may also provide insights into aging, cancer risk and chronic conditions, extending the study's significance beyond companion dogs.

Accolade Welcomes Brightline to Trusted Partner Ecosystem

Retrieved on: 
Tuesday, February 27, 2024
Anxiety, Mental health, Caregiver, Adolescence, American Academy, ACCD, Lyra, Parent, Headspace, Health, Accolade, Nursing care plan, Frustration, Depression, Family, Burnout, ADHD, Psychiatry, Trusted Partner, Equip, Bentham Science Publishers, Partnership, Nursing

SEATTLE, Feb. 27, 2024 /PRNewswire/ -- Accolade, Inc. (Nasdaq: ACCD) announced today that Brightline, a comprehensive pediatric behavioral health solution built for children, teens, their parents, and caregivers, has joined the company's Trusted Partner Ecosystem. The Brightline partnership builds on Accolade's existing behavioral health partnerships with Headspace, Lyra, and Equip and internal capabilities, including an in-house behavioral health advocacy team, Accolade Care therapists, and consulting psychiatrists.

Key Points: 
  • Partnership expands access to high-quality, affordable adolescent and children's behavioral health services
    SEATTLE, Feb. 27, 2024 /PRNewswire/ -- Accolade, Inc. (Nasdaq: ACCD) announced today that Brightline, a comprehensive pediatric behavioral health solution built for children, teens, their parents, and caregivers, has joined the company's Trusted Partner Ecosystem.
  • The Brightline partnership builds on Accolade's existing behavioral health partnerships with Headspace, Lyra, and Equip and internal capabilities, including an in-house behavioral health advocacy team, Accolade Care therapists, and consulting psychiatrists.
  • We help them move through the daunting barriers to care access," said Nancy Costlow, Accolade Senior Director, Clinical Shared Services.
  • We are thrilled to partner with Accolade to help drive awareness of Brightline's solution and improve access to a critical benefit that is missing for many families today."

China Automotive Voice Industry Research Report 2023-2024: In OEM Market, 46 Brands Install Automotive Voice as a Standard Configuration in 2023 - ResearchAndMarkets.com

Retrieved on: 
Thursday, February 15, 2024
Vehicle Technology, Audio, Video, Other Automotive, Technology, Automotive, HiPhi, Human voice, OEM, AI, Intelligence, Lyra, Original equipment manufacturer, Language, Driver, Lynk & Co, NIO, ChatGPT, GWM, Documentation, Human, Baidu, AliOS, Geely, Air conditioning, IM Motors, Knowledge, Automotive industry, Music, Ali Baba, Internet, Mobile phone

In OEM market, 46 brands install automotive voice as a standard configuration in 2023.

Key Points: 
  • In OEM market, 46 brands install automotive voice as a standard configuration in 2023.
  • From 2019 to the first nine months of 2023, automotive voice saw rising installations and installation rate.
  • In 2023, there are 46 passenger car brands boasting automotive voice installation rate of 100%, including AITO, Avatr, HiPhi, Rising Auto, ZEEKR, Voyah, Li Auto, Lynk & Co, Tank, NIO, and Xpeng.
  • In 2023, over 20 million vehicles are equipped with automotive voice, with the installation rate higher than 80%.

Evergreen Announces Key Updates to Leadership and Organization

Retrieved on: 
Thursday, February 1, 2024
SAN, Growth, MSP, Lyra, Culture, Small business, Management

SAN FRANCISCO, Feb. 1, 2024 /PRNewswire-PRWeb/ -- Evergreen, a family of leading managed IT services and software companies today announced key transformational business updates to capitalize on the outstanding performance of its regional platform businesses. The initiatives include two promotions, the launch of a new vertical business unit, and the union of Lyra Technology Group; ultimately aligning with Evergreen's commitment to innovation and its positioning for sustained success in the IT services industry.

Key Points: 
  • "Tim, Elliott and DJ took a leap of faith and joined Evergreen in our early days of building the company.
  • They went on to lead our regional MSP platforms where they served as Evergreen culture carriers and strategic advisors to our operating company CEOs.
  • Their new, major leadership roles at Evergreen reflect their personal growth and contributions to Evergreen over the past six years.
  • Their appointments position Evergreen for continued growth and evolution in the years and decades to come," said Jeff Totten, Founder and CEO of Evergreen.

SHAREHOLDER ALERT: Kaskela Law LLC Announces Investigation of Lyra Therapeutics, Inc. (NASDAQ: LYRA) and Encourages Investors to Contact the Firm

Retrieved on: 
Saturday, November 11, 2023
Acquisition, LYRA, Lyra

PHILADELPHIA, Nov. 11, 2023 (GLOBE NEWSWIRE) -- Kaskela Law LLC announces that it is investigating Lyra Therapeutics, Inc. (NASDAQ: LYRA) (“Lyra”) on behalf of the company’s investors.

Key Points: 
  • PHILADELPHIA, Nov. 11, 2023 (GLOBE NEWSWIRE) -- Kaskela Law LLC announces that it is investigating Lyra Therapeutics, Inc. (NASDAQ: LYRA) (“Lyra”) on behalf of the company’s investors.
  • Lyra stockholders are encouraged to contact Kaskela Law LLC (D. Seamus Kaskela, Esq.
  • Kaskela Law LLC exclusively represents investors in securities fraud, corporate governance, and merger & acquisition litigation on a contingent basis.
  • For additional information about Kaskela Law LLC please visit www.kaskelalaw.com .

Rigetti Computing Reports Third Quarter 2023 Results

Retrieved on: 
Thursday, November 9, 2023
Air Force Research Laboratory, Sale, Rigetti Computing, Research, Innovation, QUIC, SQMS, HSBC, QPU, DARPA, Feasibility study, PIN, Algorithm, IDIQ, Machine learning, Area studies, University, Partnership, Lyra, AFRL, NISQ, Government, Architecture, Rare-earth element, Television, Cryptocurrency, Fermilab

BERKELEY, Calif., Nov. 09, 2023 (GLOBE NEWSWIRE) -- Rigetti Computing, Inc. (Nasdaq: RGTI) (“Rigetti” or the “Company”), a pioneer in full-stack quantum-classical computing, today announced its financial results for the third quarter ended September 30, 2023.

Key Points: 
  • BERKELEY, Calif., Nov. 09, 2023 (GLOBE NEWSWIRE) -- Rigetti Computing, Inc. (Nasdaq: RGTI) (“Rigetti” or the “Company”), a pioneer in full-stack quantum-classical computing, today announced its financial results for the third quarter ended September 30, 2023.
  • In the third quarter of 2023 Rigetti expanded its QPU customer base with its delivery of a 9-qubit quantum processing unit (QPU) to another premier national laboratory.
  • In September 2023, Rigetti was awarded a DARPA IMPAQT contract to advance quantum algorithms for solving combinatorial optimization problems.
  • Additionally, in October 2023, Rigetti was awarded an Innovate UK grant as part of the Feasibility Studies in Quantum Computing Applications competition.

Lyra Therapeutics Reports Third Quarter 2023 Financial Results and Provides Corporate Update

Retrieved on: 
Tuesday, November 7, 2023
Mometasone, Research, Food, Public expenditure, Polyp, Bronchitis, Regulation of tobacco by the U.S. Food and Drug Administration, Network congestion, Sinusitis, COVID-19, Common, New Drug Application, CT, Depreciation, Safety, CRS, MF, Therapy, Investment, Patient, LYRA, Nursing, Pharmaceutical industry, Medical device, Birth control, Lyra

WATERTOWN, Mass., Nov. 07, 2023 (GLOBE NEWSWIRE) -- Lyra Therapeutics, Inc. (Nasdaq: LYRA) (“Lyra” or the “Company”), a clinical-stage biotechnology company developing long-acting anti-inflammatory therapies for the localized treatment of chronic rhinosinusitis (CRS), today reported its financial results for the third quarter ended September 30, 2023 and provided a corporate update.  

Key Points: 
  • The Company plans to submit results of the BEACON study for presentation at an upcoming medical meeting.
  • In August 2023, Lyra announced completion of enrollment in the pivotal Phase 3 ENLIGHTEN I clinical trial.
  • Cash, cash equivalents and short-term investments as of September 30, 2023 were $102.6 million, compared with $116.2 million at June 30, 2023.
  • Net loss for the quarter ended September 30, 2023 was $15.7 million compared to $14.8 million for the same period in 2022.

INVESTOR ALERT: Abbott Cooper PLLC Announces Investigation into Lyra Therapeutics, Inc.; Urges Lyra Stockholders to Contact Abbott Cooper Regarding Their Legal Rights

Retrieved on: 
Saturday, November 4, 2023
LYRA, Lyra

STAMFORD, Conn., Nov. 04, 2023 (GLOBE NEWSWIRE) -- Abbott Cooper PLLC is investigating Lyra Therapeutics, Inc. (Nasdaq: LYRA) (“Lyra” or the “Company”) on behalf of the Company’s investors.

Key Points: 
  • STAMFORD, Conn., Nov. 04, 2023 (GLOBE NEWSWIRE) -- Abbott Cooper PLLC is investigating Lyra Therapeutics, Inc. (Nasdaq: LYRA) (“Lyra” or the “Company”) on behalf of the Company’s investors.
  • Lyra stockholders are encouraged to contact Abbott Cooper PLLC by calling (475) 333-0674, emailing [email protected] or by filling out a contact from on our website at www.abbottlawyer.com for additional information about this investigation as well as their legal rights and options.
  • Abbott Cooper PLLC is dedicated to shareholders’ rights and empowering shareholders through strategic counsel and legal advocacy.
  • For additional information about Abbott Cooper PLLC, please visit www.abbottlawyer.com .